. 2014 May 20;3(5):565–580. doi: 10.1016/j.molmet.2014.04.010

Table 2.

Basal parameters of C, CMS, HF and HFMS mice after 4 weeks of therapeutic MDS.

	C	CMS	HF	HFMS
Liver weight [g]	1.40 ± 0.04^a	1.56 ± 0.04^ac	1.83 ± 0.11^b	1.70 ± 0.08^bc
% Liver/body weight	4.37 ± 0.12^ab	4.58 ± 0.07^a	4.29 ± 0.13^ab	4.08 ± 0.10^b
VAT weight [g]	1.84 ± 0.15^a	2.15 ± 0.17^a	4.80 ± 0.37^b	4.56 ± 0.27^b
% VAT/body weight	5.67 ± 0.35^a	6.28 ± 0.36^a	11.19 ± 0.52^b	10.94 ± 0.38^b
Blood glucose [mg/dl]	136.9 ± 4.2^a	146.8 ± 4.2^a	171.6 ± 5.5^b	167.7 ± 1.9^b
Plasma insulin [ng/ml]	1.42 ± 0.13^a	2.15 ± 0.48^ab	3.68 ± 0.70^b	3.01 ± 0.57^b
Plasma total adiponectin [μg/ml]	22.77 ± 1.46	20.64 ± 1.13	19.84 ± 0.76	18.93 ± 0.71
Plasma HMW adiponectin [μg/ml]	5.46 ± 0.34	5.32 ± 0.32	5.16 ± 0.46	4.91 ± 0.31
HMW/total adiponectin [%]	24.08 ± 0.82	25.89 ± 1.20	25.81 ± 1.71	25.81 ± 0.80

Data are presented as mean ± SEM (n = 7–9). Different subscript letters indicate statistical significance (p < 0.05). Visceral adipose tissue (VAT) was calculated by summing up the weight of epididymal, perirenal and mesenteric adipose tissue.